A multi-centre, randomized, parallel-group, single blind Phase II trial to evaluate the pharmacokinetics and PKPD relationship of trazodone after single and repeated oral doses in children from 2 t...
This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Italy · Spain
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 36
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco ACRAF S.p.A (Angelini S.p.A.)
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Italy, Spain
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2018-001166-42
- Official title
Show the full official title
A multi-centre, randomized, parallel-group, single blind Phase II trial to evaluate the pharmacokinetics and PKPD relationship of trazodone after single and repeated oral doses in children from 2 t...
Recruitment & locations
TerminatedItaly · Spain
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Aziende Chimiche Riunite Angelini Francesco ACRAF S.p.A (Angelini S.p.A.).
Is this study still recruiting?
The historical registry lists this study as terminated.
